In a recent segment of NBC news feature, Alister Campbell, VP of Dotmatics, discusses how AI is used to analyze massive datasets, predict which compounds are most likely to work, and reduce the trial and error that can slow drug development for years.
Campbell explains how Dotmatics is helping customers move beyond fragmented data systems and manual workflows by integrating AI into their scientific platforms, enabling researchers to design better experiments and make faster, smarter decisions.
Watch the full segment to hear how Dotmatics is reshaping the future of scientific discovery with AI.